Effects of para–toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial-Reference-Cited by-同舟云学术

Effects of para–toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial

Published:2016-08 Issue: Volume:98 Page:43-50
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Li Shi-yue,Li Qiang,Guan Wei-jie,Huang Jiang,Yang He-ping,Wu Guo-ming,Jin Fa-guang,Hu Cheng-ping,Chen Liang-an,Xu Guo-liang,Liu Shou-zhi,Wu Chang-gui,Han Bao-hui,Xiang Ying,Zhao Jian-ping,Wang Jie,Zhou Xin,Li Hui-ping,Zhong Nan-shan

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Major causes of death among men and women in China;He;N. Engl. J. Med.,2005

2. Lung cancer in China: challenges and interventions;She;Chest,2013

3. Variation in survival of patients with lung cancer in Europe, 1985–1989. EUROCARE Working Group;Janssen-Heijnen;Eur. J. Cancer,1998

4. Bronchoscopic management for malignant airway obstruction;Mitchell;Adv. Ther.,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventional bronchoscopy in lung cancer treatment;Breathe;2024-06

2. Endotracheal enucleation and para‐toluenesulfonamide injection for adenoid cystic carcinoma in the upper trachea: A novel therapeutic approach;Thoracic Cancer;2024-04-18

3. Overcoming Solubility Challenges: Liposomal isoCoQ‐Carbazole as a Promising Anti‐Tumor Agent for Inoperable and Radiation‐Insensitive cancers;ChemBioChem;2024-04-18

4. Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents;Gels;2024-01-05

5. Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to αPD-1 therapy in triple-negative breast cancer;Biomedicine & Pharmacotherapy;2023-11